Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Aspire Biopharma Holdings ( (ASBP) ) just unveiled an announcement.
On November 4, 2025, Aspire Biopharma Holdings‘ stockholders approved two significant proposals at a Special Meeting. The first proposal granted the board discretionary authority to amend the company’s certificate of incorporation to effect a reverse stock split of common stock within a one-year timeframe. The second proposal approved the issuance of more than 19.99% of outstanding shares upon exercise of Convertible Promissory Notes, adhering to Nasdaq rules, with a specified floor price for conversion.
More about Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc. operates in the biopharmaceutical industry, focusing on developing innovative therapies to address unmet medical needs.
Average Trading Volume: 22,293,824
Technical Sentiment Signal: Sell
Current Market Cap: $17.18M
For a thorough assessment of ASBP stock, go to TipRanks’ Stock Analysis page.